A phase II trial of neoadjuvant ABI-007, carboplatin, and gemcitabine (ACG) in patients with locally advanced carcinoma of the bladder.
David C. Smith
No relevant relationships to disclose
Petros Grivas
No relevant relationships to disclose
Stephanie Daignault
No relevant relationships to disclose
Khaled Hafez
No relevant relationships to disclose
David P. Wood
No relevant relationships to disclose
Cheryl T. Lee
No relevant relationships to disclose
James E. Montie
No relevant relationships to disclose
Alon Z. Weizer
No relevant relationships to disclose
Jeffrey Montgomery
No relevant relationships to disclose
Maha Hussain
No relevant relationships to disclose